- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Lyka Labs promoters settle case with Sebi in Rs 3.07 lakh over alleged violation of disclosure lapses
The order came after the applicants filed settlement applications for proposing to settle by neither "admitting nor denying the findings of fact and conclusions of law".
New Delhi: Kunal N Gandhi and Nehal N Gandhi, promoters of Lyka Labs has settled with capital markets regulator Sebi a case regarding alleged violation of disclosure lapses.
The order came after the applicants filed settlement applications for proposing to settle by neither ''admitting nor denying the findings of fact and conclusions of law''.
''The proceedings that may be initiated against the applicants for the violations are settled qua the applicants,'' Sebi's Whole Time Members' Ashwani Bhatia and Ananth Narayan G said in the settlement order passed on Monday.
In November 2021, Ipca Laboratories Ltd made an open offer for the purchase of shares of Lyka under the SAST (Substantial Acquisition of Shares and Takeovers) norms.
During the course of open offer, it was observed that there were three instances of delayed disclosures by Kunal N Gandhi and Nehal N Gandhi under SAST rules which were intimated by the merchant banker to Sebi.
The settlement application was filed before Sebi on November 17, 2022 and the High Powered Advisory Committee of the regulator on December 14, 2022 recommended the case be settled upon payment of the settlement charges on the basis of joint and several liability. After Kunal N Gandhi and Nehal N Gandhi paid the respective amount of Rs 3.07 lakh, Sebi issued the settlement order.
Read also: SEBI bans Lyka Labs for 3 years for manipulating GDR to raise Rs 37 crore
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751